Toggle light / dark theme

Deep Knowledge Group is delighted to have supported and participated in the landmark International Longevity Policy and Governance and AI for Longevity Summits that took place on November 12th at King’s College London, which gathered an unprecedented density and diversity of speakers and panelists at the intersection of Longevity, AI, Policy and Finance. The summits were organized by Longevity International UK and the AI Longevity Consortium at King’s College London, with the strategic support of Deep Knowledge Group, Aging Analytics Agency, Ageing Research at King’s (ARK) and the Biogerontology Research Foundation. Together they managed to attract the interest of major financial corporations, insurance companies, investment banks, Pharma and Tech corporations, and representatives of international governmental bodies, organisations and embassies, as well as leading media, and featured presentations and panel discussions from top executives and directors of Prudential, Barclays Business UK, HSBC, AXA, L&G, Longevity. Capital, Longevity Vision Fund, Juvenescence, the UK Office of AI, Microsoft, NVIDIA, Babylon Health, Huawei Europe, Insilico Medicine, Longevity International UK, the Longevity AI Consortium and others.


November 14, 2019, London, UK: Deep Knowledge Group executives Dmitry Kaminksiy and Eric Kihlstrom spoke at a landmark one-day event held yesterday at King’s College London with the strategic support Deep Knowledge Group. The event united two Longevity-themed summits under the shared strategic agenda of enabling a paradigm shift from treatment to prevention and from prevention to Precision Health via the synergistic efforts of science, industry, AI, policy and governance, to enable the UK to become an international leader in Healthy Longevity.

If Goldman Sachs’ new tool launches through Marcus, a human-digital hybrid approach would be a wise choice.


Goldman Sachs created a market-ready robo advisor and is mulling how to launch it, Financial Planning reports. The automated platform will represent Goldman’s digital entry into the smaller investor market, per Rachel Schnoll — who recently became the head of Goldman’s FinLife CX RIA platform — as cited by Financial Planning. The new robo advisor may be built in part on algorithms that Goldman acquired from financial life management firm United Capital, when it acquired the company for $750 million in May.

The new robo advisor could be introduced to the market via Goldman’s Marcus segment — here’s why it would be a good match. Goldman could extend a portion of the personal touch it brings to its Private Wealth Management clients to Marcus clients by offering them financial advice via the new robo advisor.

This could help elevate the bank’s play to target more retail banking customers, and could make up for the fact that the high interest rate Marcus boasts slipped from 2.25% to 1.9% since July. But Marcus isn’t the only potential route to market: Goldman is also considering launching its robo tech to financial advisors on the United Capital platform, per Schnoll.

MayMaan’s potential, explains Doron Shmueli, extends beyond the financial significance of replacing gasoline with water and ethanol. “It is geopolitical. There is a huge advantage to taking away the importance of fuel from terror-sponsoring countries. Countries like China vote against us in the UN because they are blackmailed by those countries.”

Eitan predicts that their water and ethanol-based fuel technology will eventually trickle down to passenger cars, but that it will take time, due to the conservative nature of the auto industry, which is currently embracing electric technology.

When Yehuda showed his revolutionary technology to Nakash, he advised him not to publicize the product, but remain in “stealth mode,” until the product was fully developed. “We have stayed under the radar for the past six years, but we decided that this is the right time to expose ourselves and talk to people and let the world know that such a solution exists,” says Yehuda.

When the first smartphones arrived, few people understood how they would change our reality. Today, our internet-connected mobile device maps our travel, manages our finances, delivers our dinner, and connects us to every corner of human knowledge. In less than a generation, it has become almost an extension of our central nervous system — so indispensable that we can’t imagine leaving home without it to guide us.

We are about to embark on another journey even more important to every individual and to human society. We are entering the age of genomics, an amazing future that will dramatically improve the health outcomes of people across the planet. Soon, we won’t be able to imagine a time when we left home without knowledge of our genome to guide us.

But this future isn’t a generation away. As early as 2020, I believe we will be living in a world where software uses knowledge of our personal genome to guide us, like a health GPS, toward choices that are appropriate for us as individuals. From the foods we choose to eat to the medicines we take to prevent or cure disease, from helping us avoid exposure to environmental risks to eradicating thousands of genetic diseases, genomics will reveal such immense possibilities that it will feel as if we can see and hear for the first time.

But the very features of AI that have allowed it to be so successful in other arenas also make it dangerous when applied to the financial world. These threats mirror the problems that created the last financial crisis — when complex derivatives and poorly understood subprime mortgages sent the world into a deep depression — and must be taken seriously.


As AI gains a foothold on Wall Street it could fundamentally change the way our financial system works. It could also cause financial chaos.

Been saying this for years… https://www.wired.com/story/whats-blockchain-good-for-not-much/?bxid=5c4919973f92a44c62158e66&cndid=53434316&esrc=desktopInterstitialF&source=EDT_WIR_NEWSLETTER_0_DAILY_ZZ&utm_brand=wired&utm_campaign=aud-dev&utm_mailing=WIR_Daily_102819&utm_medium=email&utm_source=nl&utm_term=list1_p4&fbclid=IwAR1_AH0QoxdVi-RVcK1Si22D_yBQMP2RpMBmPXM3KlCpaG_QofzGrONWWHQ#


Not long ago, blockchain technology was touted as a way to track tuna, bypass banks, and preserve property records. Reality has proved a much tougher challenge.

Immortality has gone secular. Unhooked from the realm of gods and angels, it’s now the subject of serious investment – both intellectual and financial – by philosophers, scientists and the Silicon Valley set. Several hundred people have already chosen to be ‘cryopreserved’ in preference to simply dying, as they wait for science to catch up and give them a second shot at life. But if we treat death as a problem, what are the ethical implications of the highly speculative ‘solutions’ being mooted?

Of course, we don’t currently have the means of achieving human immortality, nor is it clear that we ever will. But two hypothetical options have so far attracted the most interest and attention: rejuvenation technology, and mind uploading.

Like a futuristic fountain of youth, rejuvenation promises to remove and reverse the damage of ageing at the cellular level. Gerontologists such as Aubrey de Grey argue that growing old is a disease that we can circumvent by having our cells replaced or repaired at regular intervals. Practically speaking, this might mean that every few years, you would visit a rejuvenation clinic. Doctors would not only remove infected, cancerous or otherwise unhealthy cells, but also induce healthy ones to regenerate more effectively and remove accumulated waste products. This deep makeover would ‘turn back the clock’ on your body, leaving you physiologically younger than your actual age. You would, however, remain just as vulnerable to death from acute trauma – that is, from injury and poisoning, whether accidental or not – as you were before.

Nearly half the U.S. population is projected to have one or more chronic conditions by 2030 and the need to better manage both care delivery and costs has never been greater.

At the same time, Baby Boomers are entering their “Golden Years” and seeking out preventative and lifestyle medicine to ensure that they live longer and with more personal freedom. And they want to do all of this while “aging in place” and not being relegated to the decrepit and outdated nursing homes of their own parents’ generation. After all, we live in a new era of instant song selection, streaming movies, and Amazon home delivery.

We face complexity, ambiguity, and uncertainty about the future consequences of cryptocurrency use. There are doubts about the positive and negative impacts of the use of cryptocurrencies in the financial systems. In order to address better and deeper the contradictions and the consequences of the use of cryptocurrencies and also informing the key stakeholders about known and unknown emerging issues in new payment systems, we apply two helpful futures studies tools known as the “Future Wheel”, to identify the key factors, and “System Dynamics Conceptual Mapping”, to understand the relationships among such factors. Two key scenarios will be addressed. In on them, systemic feedback loops might be identified such as a) terrorism, the Achilles’ heel of the cryptocurrencies, b) hackers, the barrier against development, and c) information technology security professionals, a gap in the future job market. Also, in the other scenario, systemic feedback loops might be identified such as a) acceleration of technological entrepreneurship enabled by new payment systems, b) decentralization of financial ecosystem with some friction against it, c) blockchain and shift of banking business model, d) easy international payments triggering structural reforms, and e) the decline of the US and the end of dollar dominance in the global economy. In addition to the feedback loops, we can also identify chained links of consequences that impact productivity and economic growth on the one hand, and shift of energy sources and consumption on the other hand.

Watch the full length presentation at Victor V. Motti YouTube Channel

We’re continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology.

James Peyer of Kronos BioVentures gave a talk about the investment aspects of rejuvenation biotechnology, first explaining the effects of the population pyramid, showing the audience why cures for age-related diseases are such a necessity, and comparing population projections. He explained the startup ecosystem in biotechnology, drug approval, and IPO prices for nascent biotechnology companies. Finally, he explained the financial issues facing startup biotechnology companies and his company’s role in helping these companies achieve their goals.

[/p].